Skip to main navigation

News
Investors
Careers
Contact

About Us
Our Approach
- What We Do
- Partnering
Patients & Providers
Science & Pipeline
Investors
Careers
- Culture
- Job Openings
Contact
Home
Menu Menu

Press Releases

Overview
Events & Presentations
Stock Information
Press Releases
Corporate Governance
SEC Filings
- Quarterly Results
Contact
Email Alerts

Year

KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market

01-08-2021

Pagination

First page
Previous page
…
Page 7
Page 8
Current page 9

About Us
Our Approach
- What We Do
- Partnering
Patients & Providers
Science & Pipeline
Investors
Careers
- Culture
- Job Openings
Contact
Home

© 2023 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use